Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
01 1Biophore India Pharmaceuticals Pvt Ltd
02 1ChemWerth Inc
03 1Transo-Pharm USA LLC
04 1Transo-Pharm Handels GmbH
05 1ALP Pharm
06 1Alembic Pharmaceuticals Limited
07 1F.I.S. Fabbrica Italiana Sintetici
08 1GSK
09 1MSN Laboratories
10 1ScinoPharm Taiwan, Ltd
11 1Shouyuan Chemical
12 1Sionc Pharmaceuticals
13 1Synbias Pharma Limited Liability Company
01 2China
02 1Germany
03 4India
04 1Italy
05 1Taiwan
06 2U.S.A
07 1Ukraine
08 1United Kingdom
01 6Active
02 1Inactive
03 6Blank
01 13Blank
01 13Blank
01 1WC-0273A3
02 12Blank
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : Reviewed
Rev. Date : 2020-10-23
Pay. Date : 2019-12-12
DMF Number : 35049
Submission : 2020-08-12
Status : Active
Type : II
ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
GDUFA
DMF Review : Reviewed
Rev. Date : 2024-11-04
Pay. Date : 2024-10-25
DMF Number : 36081
Submission : 2021-07-22
Status : Active
Type : II
Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39030
Submission : 2023-11-29
Status : Active
Type : II
NDC Package Code : 65129-1265
Start Marketing Date : 2023-12-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-03-22
Pay. Date : 2023-03-01
DMF Number : 37544
Submission : 2022-11-30
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-11-09
Pay. Date : 2016-11-14
DMF Number : 30575
Submission : 2016-05-25
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-02-15
Pay. Date : 2021-12-15
DMF Number : 36305
Submission : 2021-10-11
Status : Active
Type : II
NDC Package Code : 54893-0118
Start Marketing Date : 2021-10-11
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24376
Submission : 2010-11-01
Status : Inactive
Type : II
Date of Issue : 2021-03-25
Valid Till : 2023-05-11
Written Confirmation Number : WC-0273A3
Address of the Firm :
NDC Package Code : 76055-0048
Start Marketing Date : 2022-12-21
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
A Nelarabine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nelarabine, including repackagers and relabelers. The FDA regulates Nelarabine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nelarabine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Nelarabine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Nelarabine supplier is an individual or a company that provides Nelarabine active pharmaceutical ingredient (API) or Nelarabine finished formulations upon request. The Nelarabine suppliers may include Nelarabine API manufacturers, exporters, distributors and traders.
click here to find a list of Nelarabine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 13 companies offering Nelarabine
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?